| Members | 
targetComponentId | 
| Ara nobilis | 
Diopsittaca nobilis (organism) | 
| Ara noblis cumanensis | 
Diopsittaca nobilis subspecies cumanensis (organism) | 
| Arachnia propionica | 
Pseudopropionibacterium propionicum (organism) | 
| Aratinga guarouba | 
Guaruba guarouba (organism) | 
| Arcanobacterium bernardiae | 
Trueperella bernardiae (organism) | 
| argatroban 100 mg/ml, injektionsvätska, lösning, flaska 2,5 ml | 
Product containing precisely argatroban 100 milligram/1 milliliter conventional release solution for injection (clinical drug) | 
| Arhinencephaly | 
Holoprosencephaly sequence | 
| aripiprazol 7,5 mg/ml, injektionsvätska, lösning, flaska | 
Aripiprazole 7.5 mg/mL solution for injection | 
| Arizona infection | 
Salmonella enterica subspecies arizonae infection (disorder) | 
| operation av arm | 
Surgical repair of upper extremity | 
| Arteriography of unlisted intra-abdominal arteries | 
Angiography of artery | 
| Arteriography of unlisted site | 
Angiography of artery | 
| arteriopatisk impotens | 
Erectile dysfunction due to arterial disease (disorder) | 
| klinisk handläggningsplan för artrit | 
Arthritis clinical management plan (record artifact) | 
| Arthroascus schoenii | 
Saccharomycopsis schoenii (organism) | 
| Arthrobacter duodecadis | 
Tetrasphaera duodecadis (organism) | 
| Arthrobacter flavescens | 
Microbacterium flavescens (organism) | 
| Arthrobacter siderocapsulatus | 
Pseudomonas putida | 
| Arthrobacter terregens | 
Microbacterium terregens (organism) | 
| Arthrobacter tumescens | 
Terrabacter tumescens | 
| Arthroderma cajetani | 
Paraphyton cookei | 
| Arthropathy associated with a condition classifiable elsewhere | 
Arthropathy associated with another disorder | 
| Arthropathy associated with a mycosis, NEC | 
Arthropathy associated with a mycosis | 
| Arthropathy associated with bacterial disease, NEC | 
Arthropathy associated with bacterial disease | 
| Arthropathy associated with helminthiasis, NEC | 
Arthropathy associated with helminthiasis | 
| Arthropathy associated with viral disease, NEC | 
Arthropathy associated with viral disease | 
| Arthroplasty - action | 
Reconstruction - action | 
| Arthrotomy of hip | 
Hip joint incision | 
| Arthrotomy of knee for infection | 
Arthrotomy of knee | 
| Arthrotomy of knee for infection with drainage | 
Arthrotomy of knee with drainage | 
| Arthrotomy of knee for infection with exploration | 
Arthrotomy of knee with joint exploration | 
| Arthrotomy of knee for infection with removal of foreign body | 
Arthrotomy of knee | 
| artikainhydroklorid 40 mg + adrenalin 10 mikrogram, injektionsvätska, lösning, flaska | 
Product containing only articaine and epinephrine in parenteral dose form (medicinal product form) | 
| artikainhydroklorid 40 mg/ml + adrenalin (1:200 000), injektionslösning | 
Product containing only articaine and epinephrine in parenteral dose form (medicinal product form) | 
| Articular cartilage disorder of other site | 
Articular cartilage disorder | 
| Artificial insemination with sperm washing and capacitation | 
Artificial insemination with sperm washing and capacitation | 
| askorbinsyra 250 mg, tuggtablett med apelsinsmak | 
Product containing precisely ascorbic acid 250 milligram/1 each conventional release chewable tablet (clinical drug) | 
| Aseptic necrosis of other specified site, NEC | 
Aseptic necrosis | 
| biverkning av aserbin | 
Adverse reaction to benzoic acid and/or malic acid and/or salicylic acid ester (disorder) | 
| Aspartic proteinase | 
Aspartic proteinase | 
| Aspergillus amstelodami | 
Aspergillus montevidensis (organism) | 
| Aspergillus hollandicus | 
Aspergillus montevidensis (organism) | 
| Aspiration of joint | 
Arthrocentesis | 
| Aspiration of unspecified fluid | 
Pulmonary aspiration of fluid | 
| acetylsalicylsyra 400 mg + kodein 8 mg, dispergerbar tablett | 
Aspirin and codeine only product in oral dose form | 
| acetylsalicylsyra 500 mg + kodein 8 mg, dispergerbar tablett | 
Aspirin and codeine only product in oral dose form | 
| acetylsalicylsyra 227,5 mg, tuggummitablett | 
Aspirin only product in oral dose form | 
| acetylsalicylsyra 227,5 mg, medicinskt depåtuggummi | 
Aspirin only product in oral dose form | 
| acetylsalicylsyra 300 mg, dispergerbar tablett | 
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) | 
| acetylsalicylsyra 300 mg, löslig tablett | 
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) | 
| acetylsalicylsyra 500 mg, löslig tablett | 
Aspirin 2.5 mg/mL oral solution | 
| acetylsalicylsyra 800 mg, enterotablett | 
Aspirin only product in oral dose form | 
| acetylsalicylsyra 800 mg, tablett med modifierad frisättning | 
Aspirin only product in oral dose form | 
| extrakt av acetylsalicylsyra | 
Product containing aspirin (medicinal product) | 
| acetylsalicylsyra 500 mg + papaveretum 7,71 mg, dispergerbar tablett | 
Aspirin and papaveretum only product | 
| bedömning enligt CADL-2 (communication abilities of daily living, second edition) | 
Assessment using Communication Activities of Daily Living Second Edition (procedure) | 
| bedömning enligt WHO:s verktyg för skattning av frakturrisk, FRAX | 
Hip fracture probability assessment using FRAX (fracture risk assessment tool) | 
| bedömning enligt WHO:s verktyg för skattning av osteoporotisk frakturrisk, FRAX | 
Osteoporotic fracture probability assessment using osteoporotic fracture risk assessment tool (procedure) | 
| tillfällig försämring och akutbehandling av astma sedan förra besöket | 
Emergency asthma patient visit since last encounter (situation) | 
| Asthma causes daytime symptoms 1 to 2 times per month | 
Asthma causes daytime symptoms 1 to 2 times per month (finding) | 
| Asthma causes daytime symptoms 1 to 2 times per week | 
Asthma causes daytime symptoms 1 to 2 times per week (finding) | 
| Asthma causes daytime symptoms most days | 
Asthma causes daytime symptoms most days (finding) | 
| Asthma causes night symptoms 1 to 2 times per month | 
Asthma causes night symptoms 1 to 2 times per month (finding) | 
| klinisk handläggningsplan för astma | 
Asthma clinical management plan | 
| Asthma limits walking on the flat | 
Asthma limits walking on the flat (finding) | 
| astma med status asthmaticus | 
Acute severe exacerbation of asthma (disorder) | 
| astrocytom | 
Astrocytoma | 
| Astrovirus | 
Family Astroviridae (organism) | 
| ataxi samtidig med och orsakad av cerebrotendinös xantomatos | 
Ataxia due to cerebrotendinous xanthomatosis | 
| Atherosclerosis of other specified arteries | 
Atherosclerosis | 
| Atorvastatin calcium 10mg tablet | 
Atorvastatin (as atorvastatin calcium) 10 mg oral tablet | 
| Atorvastatin calcium 20mg tablet | 
Atorvastatin (as atorvastatin calcium) 20 mg oral tablet | 
| Atorvastatin calcium 40mg tablet | 
Atorvastatin (as atorvastatin calcium) 40 mg oral tablet | 
| atosiban 7,5 mg/ml, infusionskoncentrat, flaska 5 ml | 
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) | 
| Atovaquone+proguanil hydrochloride | 
Product containing atovaquone and proguanil (medicinal product) | 
| atrakuriumbesylat 100 mg/ 10 ml, lösning | 
Atracurium besilate 10 mg/mL solution for injection | 
| förmaksmyxom med lentiginos | 
Carney complex (disorder) | 
| Atrophic age-related macular degeneration | 
Nonexudative age-related macular degeneration (disorder) | 
| Atrophic glossitis | 
Atrophy of tongue papillae | 
| atropin 2,1 mg + pralidoxim 600 mg, lösning, en autoinjektor | 
Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) | 
| Atropine sulfate + edrophonium chloride 0.14mg/10mg injection | 
Product containing only atropine and edrophonium (medicinal product) | 
| atropinsulfat 0,031 %, ögondroppar | 
Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) | 
| atropinsulfat 0,062 %, ögondroppar | 
Atropine sulfate 620 microgram/mL eye solution | 
| atropinsulfat 0,1 %, ögondroppar | 
Atropine sulfate 1 mg/mL eye solution | 
| atropinsulfat 0,25 %, ögondroppar | 
Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) | 
| atropinsulfat 140 mikrogram + edrofoniumklorid 10 mg, injektionsvätska, lösning, flaska | 
Product containing only atropine and edrophonium (medicinal product) | 
| atropinsulfat 500 mikrogram/5 ml, oral lösning | 
Atropine only product in oral dose form | 
| atropinsulfat 500 mikrogram/5 ml, sockerfri lösning | 
Atropine only product in oral dose form | 
| atypisk absensepilepsi | 
Atypical absence seizure | 
| atypiskt antipsykotiskt medel | 
Anti-psychotic agent (substance) | 
| Auditory function | 
Hearing | 
| Aurantimonas altamirensis | 
Aureimonas altamirensis (organism) | 
| Aureobacterium | 
Microbacterium | 
| Aureobacterium saperdae | 
Microbacterium saperdae (organism) | 
| Aureobacterium species | 
Microbacterium | 
| syndrom med aurikulookulär anomali och läppspalt | 
Auricular abnormality, cleft lip, ocular abnormality syndrome | 
| autogen transplantation av vaskulariserad benvävnad | 
Autogenous vascularised bone | 
| Autograft | 
Autograft | 
| Autoimplant | 
Autoimplant | 
| autointoxikation | 
Intestinal dysbiosis | 
| Automobile mechanic | 
Motor vehicle mechanic |